Edition:
India

GNI Group Ltd (2160.T)

2160.T on Tokyo Stock Exchange

676JPY
19 Jan 2018
Change (% chg)

¥-3 (-0.44%)
Prev Close
¥679
Open
¥679
Day's High
¥681
Day's Low
¥658
Volume
5,160,000
Avg. Vol
6,907,149
52-wk High
¥938
52-wk Low
¥216

Select another date:

Tue, Oct 31 2017

BRIEF-GNI Group unit receives marketing approval for Bi-Ostetic Bioactive Glass Foam related product

* Says unit Berkeley Advanced Biomaterials receives marketing approval for Bi-Ostetic Bioactive Glass Foam related product in U.S. from FDA

BRIEF-GNI Group gets IND clearance by FDA for liver fibrosis treatment

* GNI Group announces clearance of investigational new drug (IND) by FDA for F351 clinical trials in the treatment of liver fibrosis

BRIEF- GNI Group unit says clearance of IND by FDA for F351 clinical trials in the treatment of liver fibrosis

* Says its wholly-owned subsidiary GNI USA, Inc had received U.S. FDA clearance on Sept. 29 (U.S. local time) for the Investigational New Drug application (IND) for F351 for U.S. clinical trials in the treatment of liver fibrosis

Select another date: